ArticleBMC pulmonary medicine2025
Prognostic factors of lung abscess: a single-center retrospective cohort study.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA lung abscess, a localized suppurative necrosis of the lung parenchyma, remains a serious condition despite modern antibiotic therapy, with many patients requiring invasive procedures due to treatment failure. Identifying these high-risk patients is crucial, but robust prognostic factors are not well-established due to methodological limitations in prior studies, such as reliance on univariate analyses or heterogeneous endpoints. We, therefore, conducted a 20-year retrospective study to identify predictors for a composite outcome of treatment failure, defined as in-hospital death, drainage, or surgery.
methodsThis single-center, retrospective cohort study included patients with lung abscesses who were hospitalized and initially managed with conservative antibiotic therapy at the Department of Pulmonology, Kameda Medical Center, between April 2004 and June 2024. The primary endpoint was treatment failure, defined as a composite of computed tomography-guided percutaneous catheter drainage of the lung abscess, surgery, and in-hospital death. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for treatment failure were calculated using multivariate logistic regression analysis, adjusting for potential predictive variables, such as age, sex, comorbidity, and abscess characteristics, based on previous studies.
resultsThis study included 109 patients (mean age: 74 years), of whom 21 (19.3%) were female. Treatment failure was observed in 17 (15.6%) patients, including 9 (8.3%) in-hospital deaths, 1 (0.9%) surgical intervention, and 11 (10.1%) cases requiring CT-guided drainage of the lung abscess. Some patients experienced multiple outcomes. The aORs for treatment failure were as follows: age (aOR = 1.01, p = 0.737), female sex (aOR = 0.31, p = 0.297), maximum abscess diameter (aOR = 1.45, p = 0.006), presence of diabetes (aOR = 0.16, p = 0.070), and presence of multilocular abscesses (aOR = 3.88, p = 0.030). Notably, the abscess cavity size and multilocular formation were significantly associated with an increased risk of treatment failure.
conclusionsAbscess size and multiloculation are significant prognostic factors of lung abscess treatment failure. Early detection through imaging and laboratory evaluations may aid in risk stratification and prompt clinical decision-making. CLINICAL
trial registrationThe participants were registered retrospectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.